logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anton Egorov

daiichi sankyo inc.
H指数:15
被引数:1,549

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03

来自DESTINY-Breast01，DESTINY-Breast02和DESTINY-Breast03的HER2-positive转移性乳腺癌患者对曲妥珠单抗deruxtecan和相关生物标志物的最佳确认反应的汇总分析

Annals of Oncology
IF65.4
2025-11-180
PRE
C. Saura; J. Cortés; S. Modi; S.-B. Kim; E. Hamilton; S.A. Hurvitz; I.E. Krop; G. Curigliano; H. Iwata; S.-A. Im; P. Herbolsheimer; M. Karnoub; A. Boran; Y. Kuwahara; A. Egorov; F. André
A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases

人表皮生长因子受体2 (HER2) 阳性转移性乳腺癌脑转移患者曲妥珠单抗deruxtecan的汇总分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-012
OAAI
Andre, F.; Cortes, J.; Curigliano, G.; Modi, S.; Li, W.; Park, Y. H.; Chung, W. -p.; Kim, S. -b.; Yamashita, T.; Pedrini, J. L.; Im, S. -a.; Tseng, L. -m.; Harbeck, N.; Krop, I.; Nakatani, S.; Tecson, K.; Ashfaque, S.; Egorov, A.; Hurvitz, S. A.
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine治疗HER2-positive转移性乳腺癌: DESTINY-Breast03试验的长期生存分析

NATURE MEDICINE
IF50
2024-06-026
OAAI
Cortes, Javier; Hurvitz, Sara A.; Im, Seock-Ah; Iwata, Hiroji; Curigliano, Giuseppe; Kim, Sung-Bae; Chiu, Joanne W. Y.; Pedrini, Jose L.; Li, Wei; Yonemori, Kan; Bianchini, Giampaolo; Loi, Sherene; Borges, Giuliano S.; Wang, Xian; Bachelot, Thomas; Nakatani, Shunsuke; Ashfaque, Shahid; Liang, Zhengkang; Egorov, Anton; Hamilton, Erika
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine在HER2-positive转移性乳腺癌脑转移患者中的随机DESTINY-Breast03试验

ESMO OPEN
IF8.3
2024-05-0116
OAAI
Hurvitz, S. A.; Kim, S. -B.; Chung, W. -P.; Im, S. -A.; Park, Y. H.; Hegg, R.; Kim, M. -H.; Tseng, L. -M.; Petry, V.; Chung, C. -F.; Iwata, H.; Hamilton, E.; Curigliano, G.; Xu, B.; Egorov, A.; Liu, Y.; Cathcart, J.; Bako, E.; Tecson, K.; Verma, S.; Cortes, J.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, 3 trial

在HER2-positive转移性乳腺癌患者中，曲妥珠单抗deruxtecan与医生选择的治疗 (DESTINY-Breast02): 一项随机，开放标签，多中心，3试验

LANCET
IF88.5
2023-05-01134
PRE
Andre, Fabrice; Park, Yeon Hee; Kim, Sung-Bae; Takano, Toshimi; Im, Seock-Ah; Borges, Giuliano; Lima, Joao Paulo; Aksoy, Sercan; Gavila Gregori, Joaquin; De Laurentiis, Michelino; Bianchini, Giampaolo; Roylance, Rebecca; Miyoshi, Yasuo; Armstrong, Anne; Sinha, Rajni; Ruiz Borrego, Manuel; Lim, Elgene; Ettl, Johannes; Yerushalmi, Rinat; Zagouri, Flora; Duhoux, Francois P.; Fehm, Tanja; Gambhire, Dhiraj; Cathcart, Jillian; Wu, Cai; Chu, Changan; Egorov, Anton; Krop, Ian
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated survival results of the randomized, phase 3 study DESTINY-Breast03
CANCER RESEARCH
IF16.6
2023-03-015
PRE
Hurvitz, Sara; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Win Yang; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier
Trastuzumab deruxtecan vs physician's choice in patients with HER2+unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine: primary results of the randomized, phase 3 study DESTINY-Breast02
CANCER RESEARCH
IF16.6
2023-03-014
PRE
Krop, Ian; Park, Yeon H.; Kim, Sung-Bae; Borges, Giuliano; Aksoy, Sercan; Gregori, Joaquin Gavila; Roylance, Rebecca; Lim, Elgene; Yerushalmi, Rinat; Zagouri, Flora; Duhoux, Francois P.; Fehm, Tanja; Takano, Toshimi; Egorov, Anton; Wu, Iris; Cathcart, Jillian; Chu, Changan; Andre, Fabrice
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine在HER2-positive转移性乳腺癌患者中的比较: 来自DESTINY-Breast03的更新结果，一项随机，开放标签，3期试验

LANCET
IF88.5
2023-01-01298
OAAI
Hurvitz, Sara A.; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study
ANNALS OF ONCOLOGY
IF65.4
2020-09-0145
OAAI
Van Cutsem, E.; Danielewicz, I; Saunders, M. P.; Pfeiffer, P.; Argiles, G.; Borg, C.; Glynne-Jones, R.; Punt, C. J. A.; Van de Wouw, A. J.; Fedyanin, M.; Stroyakovskiy, D.; Kroening, H.; Garcia-Alfonso, P.; Wasan, H.; Falcone, A.; Kanehisa, A.; Egorov, A.; Aubel, P.; Amellal, N.; Moiseenko, V
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
EUROPEAN JOURNAL OF CANCER
IF7.1
2019-03-0139
PREAI
Pearson, Andrew D. J.; Scobie, Nicole; Norga, Koenraad; Ligas, Franca; Chiodin, Davy; Burke, Amos; Minard-Colin, Veronique; Adamson, Peter; Marshall, Lynley V.; Balakumaran, Arun; Benettaib, Bouchra; Bhargava, Pankaj; Bollard, Catherine M.; Bolotin, Ellen; Bomken, Simon; Buechner, Jochen; Burkhardt, Birgit; Caron, Hubert; Copland, Christopher; Demolis, Pierre; Egorov, Anton; Farhan, Mahdi; Zugmaier, Gerhard; Gross, Thomas; Horton-Taylor, Danielle; Klapper, Wolfram; Lesa, Giovanni; Marcus, Robert; Miles, Rodney R.; Nottage, Kerri; Pacaud, Lida; Ricafort, Rosanna; Schrappe, Martin; Sterba, Jaroslav; Vezan, Remus; Weiner, Susan; Kim, Su Young; Reaman, Gregory; Vassal, Gilles

研究方向

暂未获取到该数据
J
Javier Cortés
H 指数:113论文数:1,481被引数:6.8万
J
Jillian Cathcart
H 指数:16论文数:35被引数:2,227
F
Fabrice André
H 指数:148论文数:1,829被引数:10.3万
S
Sara A. Hurvitz
H 指数:76论文数:713被引数:3.0万
S
Seock‐Ah Im
H 指数:98论文数:1,144被引数:6.9万
G
Giuseppe Curigliano
H 指数:118论文数:1,729被引数:7.3万
S
Shahid Ashfaque
H 指数:6论文数:17被引数:855
李威 封面图
李威
H 指数:107论文数:2,240被引数:7.2万
S
Sung‐Bae Kim
H 指数:74论文数:717被引数:4.2万
I
Ian E. Krop
H 指数:99论文数:859被引数:4.2万